Karus Therapeutics secures prominent role in epigenetics debate at SciBX Summit 2013

Oxford, UK, 21 August 2013 – Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, today announced its engagement with the “Epigenetics’ Second Wind” debate at the SciBX Summit on Innovation in Drug Discovery and Development to be held in Boston, USA, on 29-30 October. Karus […]